EDESA BIOTECH, INC. Operating Leases, Rent Expense
EDESA BIOTECH, INC. (EDSA) reported Operating Leases, Rent Expense of $7.00 thousand for the 6-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2024-05-10
- EDESA BIOTECH, INC. operating leases, rent expense for the quarter ending 2023-06-30 was $20.00K.
- EDESA BIOTECH, INC. operating leases, rent expense for the quarter ending 2019-09-30 was $72.00K.
- EDESA BIOTECH, INC. operating leases, rent expense for the quarter ending 2019-06-30 was $34.00K, a 70.00% increase year-over-year.
- EDESA BIOTECH, INC. operating leases, rent expense for the quarter ending 2018-06-30 was $20.00K.
- EDESA BIOTECH, INC. operating leases, rent expense for fiscal 2018 was $79.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $7.00K 10-Q · filed 2024-05-10 | |||
| 2023-06-30 | $20.00K 10-Q · filed 2023-08-09 | |||
| 2022-06-30 | $60.00K 10-Q · filed 2023-08-09 | |||
| 2019-09-30 | $72.00K derived: 10-KT 9 month − 10-Q 6 month · filed 2019-12-12 | $106.00K derived: sum of 2 quarters · filed 2019-12-12 | $126.00K 10-KT · filed 2019-12-12 | |
| 2019-06-30 | $34.00K 10-Q · filed 2019-08-14 | $54.00K 10-Q · filed 2019-08-14 | ||
| 2018-12-31 | $79.00K 10-KT · filed 2019-12-12 | |||
| 2018-06-30 | $20.00K 10-Q · filed 2019-08-14 | $40.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |